AI assistant
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013
Aug 26, 2013
31868_dirs_2013-08-26_d83b3192-be9f-4884-ac4c-9d5e0a8a4e9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-07-26
Reporting Person: Barnes Alane P (VP, General Counsel & Corp Sec)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 41931 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) | $9.95 | 2016-09-18 | Common Stock (10000) | Direct | |
| Emp. Stock Option (Right to Buy) | $7.98 | 2017-05-16 | Common Stock (3512) | Direct | |
| Emp. Stock Option (Right to Buy) | $3.26 | 2018-03-14 | Common Stock (6709) | Direct | |
| Emp. Stock Option (Right to Buy) | $1.20 | 2019-03-02 | Common Stock (13500) | Direct | |
| Emp. Stock Option (Right to Buy) | $6.68 | 2020-03-01 | Common Stock (42000) | Direct | |
| Emp. Stock Option (Right to Buy) | $4.15 | 2021-03-01 | Common Stock (30000) | Direct | |
| Emp. Stock Option (Right to Buy) | $4.73 | 2022-03-01 | Common Stock (50000) | Direct | |
| Emp. Stock Option (Right to Buy) | $1.42 | 2023-01-01 | Common Stock (100000) | Direct |
Footnotes
F1: Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.
F2: Options become exercisable at a rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
F3: 50,000 Annual Employee Stock Options become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. 50,000 Retention Stock Options become exercisbale at the rate of 50% on each of the first and second anniversaries of the date of grant.